Clinical Trials Directory

Trials / Completed

CompletedNCT03190668

Skeletal Muscle and Adipose Tissue Study

Skeletal Muscle and Adipose Tissue Concentrations of Cefazolin Comparing Two Different Dosing Regimens During Pediatric Posterior Spinal Fusion Surgery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
12 (actual)
Sponsor
University of Florida · Academic / Other
Sex
All
Age
12 Years – 20 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research study is to compare the current standard of care for prophylactic Cefazolin administered every 3 hours intravenously with continuous infusion of Cefazolin during pediatric spinal surgery.

Detailed description

Determine the skeletal muscle and adipose tissue disposition of prophylactic Cefazolin using microdialysis sampling in a cohort of patients diagnosed with idiopathic scoliosis undergoing posterior spinal fusion (PSF) for administration of Cefazolin by either continuous infusion or intermittent bolus.

Conditions

Interventions

TypeNameDescription
DRUGBolus dose of CefazolinMode of Cefazolin administration will be a intermittent bolus
DRUGContinuous Cefazolin dripMode of Cefazolin administration will be a continuous drip
DEVICEParaspinal muscle microdialysis cathetersTwo dialysis probes will be inserted into a paraspinal muscle
DEVICESubcutaneous microdialysis cathetersTwo dialysis probes will be inserted into a paraspinal subcutaneous region

Timeline

Start date
2018-05-29
Primary completion
2022-06-23
Completion
2022-06-23
First posted
2017-06-19
Last updated
2023-07-11
Results posted
2023-07-11

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03190668. Inclusion in this directory is not an endorsement.